Search
Acalabrutinib is used in the treatment of chronic lymphocytic leukemia. Acalabrutinib, is an experimental anti-cancer drug and a selective Bruton's tyrosine kinase (BTK) inhibitor. This kinase transmits signals from B-cell Receptor (BCR), and thus any genetic BTK mutation causes B-Cell immunodeficiency. Therefore, BTK inhibitors targeting B-cell signaling has shown great promise for the treatment of chronic lymphocytic leukemia (CLL).
| Items | Specification |
| Appearance | White to cream yellow powder |
| Assay | ≥98% |
| Molecular Formula | C26H23N7O2 |
| Molecular Weight | 465.50652 |
| Product parameters | |
| Cas number: | 1420477-60-6 |
| Appearance: | White to cream yellow powder |
| Purity: | 98%min |
| Package details: | 10mg/vial,1g/foil bag |
| Brand: | Fortunachem |

Guaranteed purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية